Envestnet Asset Management Inc Renalytix PLC Transaction History

Envestnet Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.51 - $4.01 $16,395 - $43,540	10,858 New	10,858 $17,000
Q1 2023 May 11, 2023	BUY	$1.93 - $3.72 $19,863 - $38,286	10,292 New	10,292 $24,000
Q3 2022 Nov 10, 2022	BUY	$1.19 - $2.78 $386 - $903	325 Added 1.92%	17,288 $22,000
Q2 2022 Aug 03, 2022	SELL	$2.45 - $7.81 $666 - $2,124	-272 Reduced 1.58%	16,963 $42,000
Q1 2022 May 04, 2022	BUY	$5.88 - $15.9 $18,380 - $49,703	3,126 Added 22.16%	17,235 $119,000
Q4 2021 Feb 04, 2022	BUY	$13.43 - $27.4 $189,483 - $386,586	14,109 New	14,109 $224,000

554K

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.